Follow
Jon Tosh
Jon Tosh
Verified email at gsk.com
Title
Cited by
Cited by
Year
Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey
L Longworth, Y Yang, T Young, B Mulhern, M Hernández Alava, ...
Health Technology Assessment, 2014
3742014
Management of rheumatoid arthritis: summary of NICE guidance
C Deighton, R O’Mahony, J Tosh, C Turner, M Rudolf
Bmj 338, 2009
1942009
Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease …
M Stevenson, R Archer, J Tosh, E Simpson, E Everson-Hock, J Stevens, ...
Health Technology Assessment 20 (35), 1-610, 2016
1512016
A review of generic preference-based measures of health-related quality of life in visual disorders
J Tosh, J Brazier, P Evans, L Longworth
Value in Health 15 (1), 118-127, 2012
1352012
The appropriateness of, and compliance with, telephone triage decisions: a systematic review and narrative synthesis
L Blank, J Coster, A O’Cathain, E Knowles, J Tosh, J Turner, J Nicholl
Journal of advanced nursing 68 (12), 2610-2621, 2012
1192012
Pragmatic intervention for increasing self-directed exercise behaviour and improving important health outcomes in people with multiple sclerosis: a randomised controlled trial
A Carter, A Daley, L Humphreys, N Snowdon, N Woodroofe, J Petty, ...
Multiple Sclerosis Journal 20 (8), 1112-1122, 2014
1072014
Health Assessment Questionnaire disability progression in early rheumatoid arthritis: systematic review and analysis of two inception cohorts
S Norton, B Fu, DL Scott, C Deighton, DPM Symmons, AJ Wailoo, J Tosh, ...
Seminars in arthritis and rheumatism 44 (2), 131-144, 2014
1062014
Utility values in National Institute for Health and Clinical Excellence (NICE) technology appraisals
JC Tosh, LJ Longworth, E George
Value in Health 14 (1), 102-109, 2011
922011
Constrained optimization methods in health services research—an introduction: report 1 of the ISPOR optimization methods emerging good practices task force
W Crown, N Buyukkaramikli, P Thokala, A Morton, MY Sir, DA Marshall, ...
Value in health 20 (3), 310-319, 2017
842017
Health economic analysis of access site practice in England during changes in practice: insights from the British Cardiovascular Interventional Society
MA Mamas, J Tosh, W Hulme, N Hoskins, G Bungey, P Ludman, ...
Circulation: Cardiovascular Quality and Outcomes 11 (5), e004482, 2018
492018
Application of constrained optimization methods in health services research: report 2 of the ISPOR optimization methods emerging good practices task force
W Crown, N Buyukkaramikli, MY Sir, P Thokala, A Morton, DA Marshall, ...
Value in health 21 (9), 1019-1028, 2018
432018
Evaluation of NHS 111 pilot sites
J Turner, A O’Cathain, E Knowles, J Nicholl, J Tosh, F Sampson, ...
Final report, 2012
352012
The Sheffield rheumatoid arthritis health economic model
J Tosh, A Brennan, A Wailoo, N Bansback
Rheumatology 50 (suppl_4), iv26-iv31, 2011
332011
Cost-effectiveness of combination nonbiologic disease-modifying antirheumatic drug strategies in patients with early rheumatoid arthritis
JC Tosh, AJ Wailoo, DL Scott, CM Deighton
The Journal of rheumatology 38 (8), 1593-1600, 2011
332011
The cost-effectiveness of sequences of biological disease-modifying antirheumatic drug treatment in England for patients with rheumatoid arthritis who can tolerate methotrexate
MD Stevenson, AJ Wailoo, JC Tosh, M Hernandez-Alava, LA Gibson, ...
The Journal of Rheumatology 44 (7), 973-980, 2017
312017
Health economic modelling of treatment sequences for rheumatoid arthritis: a systematic review
J Tosh, M Stevenson, R Akehurst
Current rheumatology reports 16, 1-19, 2014
282014
Bridging the gap between methods research and the needs of policy makers: a review of the research priorities of the National Institute for Health and Clinical Excellence
L Longworth, MJ Sculpher, L Bojke, JC Tosh
International journal of technology assessment in health care 27 (2), 180-187, 2011
252011
Pragmatic exercise intervention for people with multiple sclerosis (ExIMS trial): study protocol for a randomised controlled trial
JM Saxton, A Carter, AJ Daley, N Snowdon, MN Woodroofe, J Petty, ...
Contemporary Clinical Trials 34 (2), 205-211, 2013
232013
The incorporation of health benefits in cost utility analysis using the EQ-5D
A Wailoo, S Davis, J Tosh
School of Health and Related Research, University of Sheffield, 2010
232010
Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying antirheumatic drugs: a NICE single technology appraisal
J Tosh, R Archer, S Davis, M Stevenson, JW Stevens
Pharmacoeconomics 31, 653-661, 2013
222013
The system can't perform the operation now. Try again later.
Articles 1–20